Enrollment of Pediatric Patients in COVID-19 Interventional Trials

Mei-Sing Ong; Ann Chen Wu; Florence T Bourgeois

doi:10.1001/jamahealthforum.2023.3939

Enrollment of Pediatric Patients in COVID-19 Interventional Trials

JAMA Health Forum. 2023 Nov 3;4(11):e233939. doi: 10.1001/jamahealthforum.2023.3939.

Authors

Mei-Sing Ong¹, Ann Chen Wu¹, Florence T Bourgeois^{2

3}

Affiliations

¹ Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
² Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Massachusetts.
³ Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children's Hospital, Massachusetts.

No abstract available

Plain language summary

This cross-sectional study uses information gathered from ClinicalTrials.gov to assess the inclusion of children in COVID-19 interventional trials conducted in the US.

MeSH terms

COVID-19*
Child
Clinical Trials as Topic*
Humans
Patient Selection*

Grants and funding

R21 MD016984/MD/NIMHD NIH HHS/United States